Forte Biosciences, Inc. (FBRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.01B |
| Enterprise Value | 3.94B |
| P/E Ratio | -9.59 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 186.09 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -7.42 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.13 |
| Return On Equity | -1.06 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -64,000 |
| EBITDA | -68.27M |
| Net Income | -69.38M |
| Diluted EPS | -4.71 |
| Total Cash | 58.22M |
| Total Cash/Share | 0.33 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.75 |
| Book Value Per Share | 0.24 |
| 52-Week Change | 346.34 |
| 52-Week High | 45.36 |
| 52-Week Low | 9.1 |
| Moving Average 50 Days | 21.83 |
| Moving Average 200 Days | 23.12 |
| Average Volume | 433,558 |
| Shares Outstanding | 13.89M |
| % Held by Institutions | 9.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 28, 2024 |